東北製藥(000597.SZ)向山西省捐贈災區急需藥品以支持防汛救災工作
格隆匯10月17日丨東北製藥(000597.SZ)公佈,近日,山西省遭受持續性強降雨侵襲,多地出現內澇、地質災害、洪水等災情,當地羣眾的生命財產安全受到巨大威脅。為積極履行上市公司社會責任,公司秉承着“不忘初心,為國製藥”的使命,向山西省捐贈災區急需的藥品以支持防汛救災工作,保障當地羣眾生命健康。2021年10月16日,公司召開第八屆董事會第五十九次會議,審議通過了《關於對外捐贈支持防汛救災的議案》,同意公司向山西省捐贈藥品用於防汛抗災。
公司本次對外捐贈藥品是為了支持防汛救災和災後疫情防治工作,符合公司積極承擔上市公司社會責任的要求。上述捐贈藥品全部為公司產品,預計將產生營業外支出約 400萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.